• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
PALB2 Interest Group

PALB2 Interest Group

  • Home
  • About the PALB2 gene
    • PALB2 mutation and cancer risks
    • A Study of Cancer Risks in PALB2 Mutation Carriers
    • Clinician Info
    • FAQS
  • Team
    • Our Team
    • Our Collaborators
  • Resources
  • Publications
  • Events
  • Contact Us

ASCO Post – Commentary on the PALB2 ACMG Management Guidelines

October 12, 2021

ASCO Post have featured the ACMG PALB2 Management Guidelines with comments from on of the authors, Dr Doug Stewart.

Dr. Stewart is Senior Investigator, Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, at the National Cancer Institute. He is also a past Chair of the ACMG Professional Practice and Guidelines Committee.

You can read the article here.

Category: Uncategorised
 
Previous Post: « PALB2 Information session 20th SEP 2021 – recording now available
Next Post: In Memoriam: David Morse Livingston, MD, Renowned Scientist and Discoverer of PALB2 »

Copyright © 2023 · PALB2 Interest Group · All Rights Reserved · Send comments to add-tr.palb2@nhs.net. Hosted by Clinical School Computing Service